
Our 12th Annual Biomarkers Congress, 21st-22nd February 2017 taking place in Manchester, UK, is an unrivalled opportunity to network, exchange ideas and discuss the latest innovations in the field with innovators and researchers from across Europe. Delegates come from a variety of areas, including biomarker research in discovery and development, companion diagnostics, data management, innovative biology, precision medicine, clinical biomarkers and more.
6 Interactive Streams:
- Biomarkers in Drug Discovery & Development – Therapeutic areas: Autoimmune, Immuno-oncology, Neuroscience, Oncology
- Personalised Medicine, Companion Diagnostics and Development
- Biomarker Discovery, Verification & Validation, and Safety – Therapeutic areas: Cardiovascular, Rheumatology, COPD, Rare Diseases and Microbiome
- Innovations in Biomarkers Research, Assay Development, Imaging, Data Management
- Biomarker in Clinical Development & Clinical Trials
- Innovative Biology- NGS & Genomic Markers, Clinical Testing and Diagnostics Development
14 pre-scheduled one to one meetings, exhibition and informal networking opportunities
The Congress will be co-located with our 4th Annual Biomarkers in Clinical Development Congress
Free Pre Congress Webinars
1. Driving Precision Medicine and Advancing Clinical Data.
October 2016.
2. Exosome Biomarkers and Diagnostics Development.
Wednesday 30th November 2016
3. Initiatives and Projects of FNIH and The Global Biomarkers Consortium.
Monday 16th January 2017